|
1
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hao K, Luk JM, Lee NP, Mao M, Zhang C,
Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC, et al: Predicting
prognosis in hepatocellular carcinoma after curative surgery with
common clinicopathologic parameters. BMC Cancer. 9:3892009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng CJ, Bahal R, Babar IA, Pincus Z,
Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM,
et al: MicroRNA silencing for cancer therapy targeted to the tumour
microenvironment. Nature. 518:107–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
White NM, Fatoohi E, Metias M, Jung K,
Stephan C and Yousef GM: Metastamirs: A stepping stone towards
improved cancer management. Nat Rev Clin Oncol. 8:75–84. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen R, Alvero AB, Silasi DA, Kelly MG,
Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T and Mor G:
Regulation of IKKbeta by miR-199a affects NF-kappaB activity in
ovarian cancer cells. Oncogene. 27:4712–4723. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li ZZ, Shen LF, Li YY, Chen P and Chen LZ:
Clinical utility of microRNA-378 as early diagnostic biomarker of
human cancers: A meta-analysis of diagnostic test. Oncotarget.
7:58569–58578. 2016.PubMed/NCBI
|
|
10
|
de Leeuw DC, Verhagen HJ, Denkers F,
Kavelaars FG, Valk PJ, Schuurhuis GJ, Ossenkoppele GJ and Smit L:
MicroRNA-551b is highly expressed in hematopoietic stem cells and a
biomarker for relapse and poor prognosis in acute myeloid leukemia.
Leukemia. 30:742–746. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stewart SA, Dykxhoorn DM, Palliser D,
Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, et
al: Lentivirus-delivered stable gene silencing by RNAi in primary
cells. RNA. 9:493–501. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Duan W, Chang Y, Li R, Xu Q, Lei J, Yin C,
Li T, Wu Y, Ma Q and Li X: Curcumin inhibits hypoxia inducible
factor-1α-induced epithelial-mesenchymal transition in HepG2
hepatocellular carcinoma cells. Mol Med Rep. 10:2505–2510.
2014.PubMed/NCBI
|
|
14
|
Lei J, Fan L, Wei G, Chen X, Duan W, Xu Q,
Sheng W, Wang K and Li X: Gli-1 is crucial for hypoxia-induced
epithelial-mesenchymal transition and invasion of breast cancer.
Tumour Biol. 36:3119–3126. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Ma Q, Xu Q, Liu H, Lei J, Duan W,
Bhat K, Wang F, Wu E and Wang Z: SDF-1/CXCR4 signaling induces
pancreatic cancer cell invasion and epithelial-mesenchymal
transition in vitro through non-canonical activation of Hedgehog
pathway. Cancer Lett. 322:169–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jayo A and Parsons M: Fascin: A key
regulator of cytoskeletal dynamics. Int J Biochem Cell Biol.
42:1614–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Adams JC: Roles of fascin in cell adhesion
and motility. Curr Opin Cell Biol. 16:590–596. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hayashi Y, Osanai M and Lee GH: Fascin-1
expression correlates with repression of E-cadherin expression in
hepatocellular carcinoma cells and augments their invasiveness in
combination with matrix metalloproteinases. Cancer Sci.
102:1228–1235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mirghasemi A, Taheriazam A, Karbasy SH,
Torkaman A, Shakeri M, Yahaghi E and Mokarizadeh A: Down-regulation
of miR-133a and miR-539 are associated with unfavorable prognosis
in patients suffering from osteosarcoma. Cancer Cell Int.
15:862015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gu L and Sun W: MiR-539 inhibits thyroid
cancer cell migration and invasion by directly targeting CARMA1.
Biochem Biophys Res Commun. 464:1128–1133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Li S, Yang X, Qiao B, Zhang Z and
Xu Y: miR-539 inhibits prostate cancer progression by directly
targeting SPAG5. J Exp Clin Cancer Res. 35:602016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu C, Zhou R, Zhou Q, Chang Y and Jiang
M: microRNA-539 suppresses tumor growth and tumorigenesis and
overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Life Sci. 166:34–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iguchi T, Aishima S, Umeda K, Sanefuji K,
Fujita N, Sugimachi K, Gion T, Taketomi A, Maehara Y and Tsuneyoshi
M: Fascin expression in progression and prognosis of hepatocellular
carcinoma. J Surg Oncol. 100:575–579. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Machesky LM and Li A: Fascin: Invasive
filopodia promoting metastasis. Commun Integr Biol. 3:263–270.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsai WC, Jin JS, Chang WK, Chan DC, Yeh
MK, Cherng SC, Lin LF, Sheu LF and Chao YC: Association of
cortactin and fascin-1 expression in gastric adenocarcinoma:
Correlation with clinicopathological parameters. J Histochem
Cytochem. 55:955–962. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Inamoto T, Taniguchi K, Takahara K,
Iwatsuki A, Takai T, Komura K, Yoshikawa Y, Uchimoto T, Saito K,
Tanda N, et al: Intravesical administration of exogenous
microRNA-145 as a therapy for mouse orthotopic human bladder cancer
xenograft. Oncotarget. 6:21628–21635. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang ZC, Gao Q, Shi JY, Guo WJ, Yang LX,
Liu XY, Liu LZ, Ma LJ, Duan M, Zhao YJ, et al: Protein tyrosine
phosphatase receptor S acts as a metastatic suppressor in
hepatocellular carcinoma by control of epithermal growth factor
receptor-induced epithelial-mesenchymal transition. Hepatology.
62:1201–1214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xue M, Pang H, Li X, Li H, Pan J and Chen
W: Long non-coding RNA urothelial cancer-associated 1 promotes
bladder cancer cell migration and invasion by way of the
hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci. 107:18–27. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen JJ, Cai WY, Liu XW, Luo QC, Chen G,
Huang WF, Li N and Cai JC: Reverse correlation between microRNA-145
and FSCN1 affecting gastric cancer migration and invasion. PLoS
One. 10:e01268902015. View Article : Google Scholar : PubMed/NCBI
|
